21 CFR 524.815
§ 524.815 Eprinomectin and praziquantel.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 524.815, § 524.815 Eprinomectin and praziquantel, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87584
- Permanent ID
ys:prov:87584@1- SHA-256
9a9c5b0d52e0bc567c938cc11aa81a07d26bd0c3843b3ddcf61106ff4a4c710e
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter (mL) of solution contains 4 milligrams (mg) eprinomectin and 83 mg praziquantel.
(b) Sponsor. See No. 000010 in § 510.600(c) of this chapter.
(c) Conditions of use in cats—(1) Amount. Using the 0.3 mL and 0.9 mL unit applicators, administer a minimum dose of 0.23 mg eprinomectin per pound body weight and 4.55 mg praziquantel per pound body weight by topical application on the dorsal midline between the base of the skull and the shoulder blades.
(2) Indications for use. For the prevention of heartworm disease caused by Dirofilaria immitis, and for the treatment and control of roundworms (adult and fourth stage larval Toxocara cati), hookworms (adult and fourth stage larval Ancylostoma tubaeforme; adult Ancylostoma braziliense), and tapeworms (adult Dipylidium caninum and Echinococcus multilocularis), in cats and kittens 7 weeks of age and older and 1.8 lbs or greater.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.